News

VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announced that the U.S. Food and Drug…
Read More...

Galapagos NV, CellPoint and AboundBio announced that both companies have entered into definitive agreements with Galapagos, propelling Galapagos into next-generation cell therapy while …
Read More...

ANI Pharmaceuticals, Inc. (ANI or the Company) announced that the Company received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for…
Read More...

Merck announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) (pronounced…
Read More...

Truveta announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable real-world data at scale. Truveta will provide Pfizer with…
Read More...

One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two of the world’s leading biotech companies - Afrigen Biologics and the…
Read More...

BioMarin Pharmaceutical Inc. announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan granted approval of the registration of VOXZOGO (vosoritide) for injection,…
Read More...

Moderna, Inc . announced an agreement in principle with the United Kingdom government to establish an mRNA Innovation and Technology Center in the UK. This state-of-the-art mRNA vaccine…
Read More...

Kinarus Therapeutics Holding AG, a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory, and ophthalmic diseases, announced publication in…
Read More...

Waters Corporation announced a collaboration with BioInfra, a pioneering contract research organization (CRO) company for the pharmaceutical and clinical fields, to jointly establish…
Read More...

Sandoz, a global leader in generic and biosimilar medicines, announced that the European Medicines Agency (EMA) has accepted the application for high concentration formulation 100 mg/mL…
Read More...

Hansa Biopharma, "Hansa" announces the recommendation by the National Institute for Health and Care Excellence (NICE) for its first-in-class treatment Idefirix in the desensitization of…
Read More...

Exelixis, Inc. and BioInvent International AB announced that the companies have entered into an option and license agreement focused on the identification and development of novel…
Read More...

Panbela Therapeutics, Inc. a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, announced the closing of its acquisition of Cancer…
Read More...

Humanigen, Inc. announced it entered into an agreement with PCI Pharma Services (PCI), a leading integrated global contract development manufacturing organization (CDMO), to provide…
Read More...

Jazz Pharmaceuticals and Redx announce the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for JZP815, a pan-RAF inhibitor for the…
Read More...

EMA has started a rolling review for a version of Comirnaty adapted to provide better protection against a specific variant or variants of SARS-CoV-2, the virus that causes COVID-19.…
Read More...

Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, and French pharmaceutical group Pierre Fabre announced that the companies have…
Read More...

Kintara Therapeutics, Inc. announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kintara's VAL-083 for the treatment of…
Read More...

Researchers from the University of Sheffield and Stanford University in the US have discovered there are specific genetic signals in people who develop severe coronavirus infection.…
Read More...